Shahram Ahari, who worked as a drug rep visiting doctors and selling Zyprexa for Eli Lilly, explains some of the tactics he was taught to use in this video. He talks about how he was told to downplay the side effects. He states the Lilly told him and other reps like him that “that weight gain is really propaganda put out by our competitors.” As reported here in The New York Times, Eli Lilly recently put a stronger warning on its Zyprexa stressing the problems it causes with weight gain.

You can learn more about pharmaceutical influence at Pharmedout.org, a new publicly funded program (funded through the Attorney General Consumer and Prescriber Education grant program) that “empowers physicians to identify and counter inappropriate pharmaceutical promotion practices.”